EANM enabling guide: how to improve the accessibility of clinical dosimetry.

Humans Radiometry / methods Iodine Radioisotopes Neuroendocrine Tumors / diagnostic imaging 3-Iodobenzylguanidine
Dosimetry Molecular radiotherapy Nuclear medicine Optimisation Quantitative imaging SPECT

Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
06 2023
Historique:
received: 11 02 2023
accepted: 04 04 2023
medline: 22 5 2023
pubmed: 22 4 2023
entrez: 22 04 2023
Statut: ppublish

Résumé

Dosimetry can be a useful tool for personalization of molecular radiotherapy (MRT) procedures, enabling the continuous development of theranostic concepts. However, the additional resource requirements are often seen as a barrier to implementation. This guide discusses the requirements for dosimetry and demonstrates how a dosimetry regimen can be tailored to the available facilities of a centre. The aim is to help centres wishing to initiate a dosimetry service but may not have the experience or resources of some of the more established therapy and dosimetry centres. The multidisciplinary approach and different personnel requirements are discussed and key equipment reviewed example protocols demonstrating these factors are given in the supplementary material for the main therapies carried out in nuclear medicine, including [

Identifiants

DOI: 10.1007/s00259-023-06226-z PMID: 37086275 PMC: PMC10287783
pubmed: 37086275
doi: 10.1007/s00259-023-06226-z
pii: 10.1007/s00259-023-06226-z
pmc: PMC10287783
doi:

Substances chimiques

Iodine-131 0
Iodine Radioisotopes 0
3-Iodobenzylguanidine 35MRW7B4AD

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1861-1868

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Eur J Nucl Med Mol Imaging. 2022 May;49(6):1778-1809
pubmed: 35284969
J Nucl Med. 2014 Jul;55(7):1047-53
pubmed: 24842891
Magn Reson Imaging. 2012 Nov;30(9):1323-41
pubmed: 22770690
Eur J Nucl Med Mol Imaging. 2010 Jun;37(6):1238-50
pubmed: 20411259
J Nucl Med. 2021 Apr;62(4):528-535
pubmed: 32859710
Lancet Gastroenterol Hepatol. 2021 Jan;6(1):17-29
pubmed: 33166497
J Nucl Med. 2013 Jan;54(1):33-41
pubmed: 23223392
J Nucl Med. 2018 Jan;59(1):75-81
pubmed: 28588150
Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1405-12
pubmed: 18491092
Phys Med. 2021 Dec 4;92:75-85
pubmed: 34875425
Nat Rev Clin Oncol. 2022 Aug;19(8):534-550
pubmed: 35725926
Med Phys. 2020 Sep;47(9):4602-4615
pubmed: 32632928
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
J Vasc Interv Radiol. 2018 Dec;29(12):1662-1670.e4
pubmed: 30217745
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2300-2309
pubmed: 35403861
Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2218-28
pubmed: 20625722
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1490-1500
pubmed: 28361189
Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1976-88
pubmed: 24915892
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nuklearmedizin. 2017;56(6):219-224
pubmed: 29533417
Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):970-988
pubmed: 29497803
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):242-246
pubmed: 36066665
Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2426-2441
pubmed: 29785514
J Nucl Med. 1992 Jun;33(6):1132-6
pubmed: 1597728
J Nucl Med. 2016 Jan;57(1):151-62
pubmed: 26471692
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):728-742
pubmed: 30506283
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1570-1584
pubmed: 33433699
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):67-72
pubmed: 33057773
Q J Nucl Med Mol Imaging. 2012 Dec;56(6):503-8
pubmed: 23358402
Eur J Nucl Med Mol Imaging. 2023 May 2;:
pubmed: 37129712
EJNMMI Phys. 2021 Jul 23;8(1):55
pubmed: 34297218
Phys Med. 2021 Dec 2;92:52-61
pubmed: 34864422
EJNMMI Phys. 2021 Nov 12;8(1):77
pubmed: 34767102
Q J Nucl Med Mol Imaging. 2019 Sep;63(3):271-277
pubmed: 31315346
J Nucl Med. 2020 Jul;61(7):1030-1036
pubmed: 31806772
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1126-34
pubmed: 23576099
EJNMMI Phys. 2020 Mar 6;7(1):15
pubmed: 32144574
EJNMMI Phys. 2018 Jul 5;5(1):12
pubmed: 29974391
J Nucl Med. 2016 Jun;57(6):872-8
pubmed: 26769864

Auteurs

Jonathan Gear (J)

Joint Department of Physics, Royal Marsden NHSFT & Institute of Cancer Research, Sutton, UK. jonathan.gear@icr.ac.uk.
ORCID: 0000-0002-4292-6149

Caroline Stokke (C)

Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Department of Physics, University of Oslo, Oslo, Norway.

Christelle Terwinghe (C)

Department of Nuclear Medicine, Universitair Ziekenhuis Leuven, Louvain, Belgium.

Silvano Gnesin (S)

Institute of Radiation Physics, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Mattias Sandström (M)

Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Sweden & Section of Medical Physics, Department of Immunology, Genetics and Pathology, Uppsala University, 751 85, Uppsala, Sweden.

Johannes Tran-Gia (J)

Department of Nuclear Medicine, University Hospital Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany.

Marta Cremonesi (M)

Radiation Research Unit, Department of Medical Imaging and Radiation Sciences, Istituto Europeo Di Oncologia, IRCCS, Milan, Italy.

Francesco Cicone (F)

Department of Experimental and Clinical Medicine, Neuroscience Research Centre, PET/RM Unit, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.
Nuclear Medicine Unit, University Hospital "Mater Domini, Catanzaro, Italy.

Fredrik Verburg (F)

Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

Roland Hustinx (R)

Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Liège, Belgium.
GIGA-CRC in Vivo Imaging, University of Liège, Liège, Belgium.

Luca Giovanella (L)

Clinic for Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

Ken Herrmann (K)

Department of Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.
German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.

Pablo Minguez Gabiña (PM)

Department of Medical Physics and Radiation Protection, Gurutzeta-Cruces University Hospital/Biocruces Health Research Institute, Barakaldo, Spain.
Department of Applied Physics, Faculty of Engineering, UPV/EHU, Bilbao, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › EANM enabling guide: how to improve the...
questionsmedicales.fr › Techniques d'investigation › Radiométrie › EANM enabling guide: how to improve the...
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes de l'iode › EANM enabling guide: how to improve the...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › EANM enabling guide: how to improve the...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Hydrocarbures halogénés › Hydrocarbures iodés › Iodobenzènes › 3-Iodobenzyl-guanidine › EANM enabling guide: how to improve the...